Ildong Pharmaceutical

South Korea
Seoul, Seoul, South Korea

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Last funding
Convertible Note / $91.1M / 2021-01-20
Articles
7
Exited on
2015-07-01

Founders and investors

No public relation records are available.